Dyadic Logo Current.jpg
Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
20 nov. 2023 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...
FFF Enterprises Inc.
FFF Enterprises Inc. Adds COVID-19 Vaccines and Respiratory Syncytial Virus (RSV) Products to Its Comprehensive, Expanding Portfolio
13 sept. 2023 13h34 HE | FFF Enterprises.com
TEMECULA, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, has partnered with...
Alcatraz AI Appoints Moderna’s Dean Geribo to Advisory Board
16 mai 2023 09h00 HE | Alcatraz AI
CUPERTINO, Calif., May 16, 2023 (GLOBE NEWSWIRE) -- Alcatraz AI, a global leader in autonomous access control solutions, today announced the appointment of Dean Geribo, Vice President, Corporate...
Moderna exercises option to license proprietary targeting technology from Autolus
12 oct. 2022 07h00 HE | Autolus Therapeutics plc
- Option exercised on undisclosed immune-oncology target following evaluation period by Moderna - - Autolus receives option exercise fee, with potential for development milestone payments plus...
Dyadic Logo Current.jpg
Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments
10 août 2022 16h00 HE | Dyadic International, Inc.
Submission of a Clinical Trial Application (CTA) with South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 study to support clinical safety of proteins produced from...
Dyadic Logo Current.jpg
Dyadic Announces Successful Toxicology Data Published in “Toxicologic Pathology”
09 mai 2022 08h30 HE | Dyadic International, Inc.
Toxicology data published in the international peer-reviewed scientific journal “Toxicologic Pathology” demonstrates excellent safety profile and lasting immunogenic response from Dyadic’s DYAI-100,...
Dyadic Logo Current.jpg
Epygen Biotech Announces Funding from India Government for Development of a COVID-19 Vaccine Using Dyadic’s Licensed C1 Protein Production Platform
13 avr. 2022 08h52 HE | Dyadic International, Inc.
India’s Department of Biotechnology, Government of India to support scale up and production of cGMP batches of SARS-CoV-2 antigenFunding earmarked to support Phase 1 and 2 clinical trials of Epygen’s...
FXCM January Single Share & Stock Baskets Report
02 mars 2022 04h00 HE | FXCM Group
LONDON, March 02, 2022 (GLOBE NEWSWIRE) -- FXCM Group, LLC (“FXCM Group’ or ‘FXCM’), the leading international provider of online foreign exchange trading, CFD trading, cryptocurrencies and related...
FXCM Group.png
FXCM January Single Share & Stock Baskets Report
02 mars 2022 04h00 HE | FXCM Group
SYDNEY, Australia, March 02, 2022 (GLOBE NEWSWIRE) -- FXCM Group, LLC (“FXCM Group” or ‘FXCM’), the leading international provider of online foreign exchange trading, CFD trading, cryptocurrencies...
Arbutus Biopharma Logo
Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit Against Moderna
28 févr. 2022 06h02 HE | Arbutus Biopharma Corporation
WARMINSTER, Pa., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...